Scarica l'app Stockscreener
8.23
0.37%
0.03
Dopo l'orario di chiusura:
8.27
0.04
+0.49%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cyclacel Pharmaceuticals Inc Borsa (CYCC) Ultime notizie
Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize
Cyclacel stock falls after paring 270% gain amid volatility concerns By Investing.com - Investing.com Canada
Cyclacel stock dips after trimming 270% surge amid volatility concerns - MSN
Cyclacel Shares Plunge 36% Amid Volatility, What's Driving the Sell-Off? - AInvest
Cyclacel stock falls after paring 270% gain amid volatility concerns - Investing.com Australia
Cyclacel Pharmaceuticals Addresses Recent Stock Price Volatility Amid Ongoing Business Developments - Quiver Quantitative
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY - Yahoo Finance
Cyclacel Pharmaceuticals Stock Plunges 37.23% - AInvest
Cyclacel Pharmaceuticals Stock Surges Amid Positive Research Findings - AInvest
What makes Cyclacel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - beatles.ru
Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday? - Benzinga
Why Cyclacel Pharmaceuticals Inc. stock attracts strong analyst attentionFree High-Accuracy Stock Picks - Newser
Cyclacel's Volatile Surge: Can This Biotech Stock Defy Gravity? - AInvest
Cyclacel Pharmaceuticals Stock Soars: Investing or Waiting? - timothysykes.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Fitters: US$1m cash added to Cyclacel deal to address stock volatility since signing - The Malaysian Reserve
Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS - MSN
Cyclacel stock soars after amendment to exchange agreement with FITTERS By Investing.com - Investing.com Nigeria
Cyclacel stock soars after amendment to exchange agreement with FITTERS - Investing.com Australia
Cyclacel sweetens Fitters acquisition deal with US$1m cash addition - The Malaysian Reserve
Cyclacel Pharmaceuticals Amends Exchange Agreement with FITTERS - TipRanks
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER - The Manila Times
Breakthrough: New Drug Shows Effectiveness Against Untreatable Youth Liver Cancer, Research Reveals - Stock Titan
Cyclacel Pharmaceuticals adjusts shareholder rights, amends stock - MSN
Cyclacel Pharmaceuticals to Acquire Fitters Sdn. Bhd. Through Share Exchange Agreement - Global Legal Chronicle
Cyclacel Pharmaceuticals Announces 1-for-15 Reverse Stock Split Effective July 7, 2025 - Nasdaq
Cyclacel Pharmaceuticals Announces Stock Split - Morningstar
Cyclacel Pharmaceuticals to Implement 1-for-15 Reverse Stock Split; Shares Fall - MarketScreener
Cyclacel Pharmaceuticals shareholders re-elect directors and approve equity plan changes - Investing.com
Cyclacel Pharmaceuticals Approves Equity Plan Amendment - TipRanks
Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock - Yahoo Finance
Why Did Cyclacel Pharmaceuticals Inc. (CYCC) Soar 13.92%? - AInvest
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Listing Rule - marketscreener.com
Cyclacel Pharmaceuticals Declares Quarterly Cash Dividend - TipRanks
Cyclacel Pharmaceuticals (CYCC) Regains Nasdaq Compliance | CYCC Stock News - GuruFocus
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM - GuruFocus
Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement - marketscreener.com
CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT | CYCC Stock News - GuruFocus
Cyclacel Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - Nasdaq
Cyclacel Dodges Delisting Risk: Stock Stabilizes Above $1, Secures Crucial Nasdaq Compliance - Stock Titan
Comparing Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Biodexa Pharmaceuticals (NASDAQ:BDRX) - Defense World
Cyclacel stock plunges to 52-week low of $1.95 amid market challenges - Investing.com Australia
(CYCCP) Proactive Strategies - news.stocktradersdaily.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com - Defense World
CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - The Manila Times
Cyclacel Pharmaceuticals Reports Q1 2025 Financial Results and Strategic Focus Shifts to Plogosertib Development - Nasdaq
Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail
Fitters Clarifies Details Of Business Unit Disposal To Cyclacel - BusinessToday Malaysia
Cyclacel Pharmaceuticals (CYCC) to Release Earnings on Monday - Defense World
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by StockNews.com - Defense World
Trend Tracker for (CYCCP) - news.stocktradersdaily.com
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Shares Scheduled to Reverse Split on Monday, May 12th - Defense World
0.64%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):